Mircera Gets FDA Approval But Will Not Be Launched
Roche Holding AG said Thursday that the U.S. Food and Drug Administration had approved its anemia treatment Mircera but that it won't launch the drug until a patent dispute with Amgen...To view the full article, register now.
Already a subscriber? Click here to view full article